CJC-1295 w/ DAC
A modified GHRH analog with Drug Affinity Complex (DAC) that extends its half-life dramatically.
Half-life
~6–8 days
Typical vial
2 mg / 5 mg
Mechanism
DAC binding to serum albumin extends GHRH activity for sustained GH release research.
Research Applications
- Extended GH studies
- Endocrine models
Handling & Storage
Store lyophilized at -20°C. Reconstitute and refrigerate.
Compliance notice: All materials are sold strictly for in vitro laboratory research. Not a drug, supplement, food, or cosmetic. Not for human or veterinary use, diagnosis, treatment, or consumption. No medical claims are made or implied. Buyers must be qualified researchers ≥21 years of age and agree to handle materials in compliance with all applicable local, state, and federal laws.